About Monal Mehta
Form D filings for Endeavor Biomedicines from 2022 to 2024 list Monal Mehta as director.
Monal Mehta first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Monal Mehta in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Monal Mehta works with at each company, as listed on that company's latest Form D.
Endeavor Biomedicines, Inc. · Form D, May 3, 2024
PE
Patrick Enright
Director
BD
Bernard Davitian
Director
JH
John Hood
Chief Executive Officer and director
VT
Vishaal Turakhia
Executive officer
CK
Chris Krueger
Executive officer
EK
Enoch Kariuki
Executive officer
KT
Karan Takhar
Director
MR
Miguel de los Rios
Executive officer
WL
Wing Lam
Director